Impact of Banff Borderline Acute Rejection Among Renal Allograft Recipients

Transplantation Proceedings

Volumn 40, Issue 7, 2008, Pages 2303-2306

  Matoza, J R A ^a   Danguilan, R A ^a   Chicano, S ^a  

^a National Kidney and Transplant Institute Philippines   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CREATININE; CYCLOSPORIN; DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC GLOMERULONEPHRITIS; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DRUG MEGADOSE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEPHROSCLEROSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTIBODY FORMATION; CADAVER; COHORT STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 51249124674     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.07.004     Document Type: Article

References (11)

1. Kee T.Y., Chapman J.R., O'Connell P.J., et al. Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. Transplantation 82 (2006) 36
2. Racusen L.C., Solez K., Colvin R.B., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 (1999) 713
3. Nankivell B.J., Borrows R.J., Fung C.L.S., et al. Natural history, risk factors and impact of subclinical rejection in kidney transplantation. Transplantation 78 (2004) 242
4. Danovitch G. Handbook of Kidney Transplantation. 4th Ed. (2005), Lippincott Williams & Wilkins, Philadelphia
5. Meehan S.M., Siegel C.T., Aronson A.J., et al. The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol 10 (1999) 1806
6. Gloor J.M., Cohen A.J., Lager D.J., et al. Subclinical rejection in tacrolimus-treated renal transplant recipients. Transplantation 73 (2002) 1965
7. Philippine Renal Disease Registry: PRDR Annual Report. Philippine Society of Nephrology and Renal Disease Control Program. National Kidney and Transplant Institute; 2003-2006
8. Rush D., Nickerson P., Gough J., et al. Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol 9 (1998) 2129
9. Nickerson P., Jeffery J., Gough J., et al. Effects of increasing baseline immunosuppression on the prevalence of clinical and subclinical rejection: a pilot study. J Am Soc Nephrol 10 (1999) 1801
10. Dias E.C.A., Veronese F.J.V., Goncalves L.F.S., et al. Molecular markers in subclinical acute rejection of renal transplants. Clin Transplant 18 (2004) 281
11. Rush D. Insights into subclinical rejection. Transplant Proc 36 suppl 2 (2004) 71S